New monthly shot could stop COVID-19 before it starts

NCT ID NCT07298434

Ongoing Prevention Sponsor: Invivyd, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called VYD2311, a monoclonal antibody that blocks the COVID-19 virus from entering cells. About 1,770 adults and teens aged 12 and older receive either VYD2311 or a placebo as a monthly shot for 3 months. The goal is to see if it safely prevents COVID-19 infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19

Contacts and locations

Show contact details

Locations

Inviviyd Investigative Site

San Diego, California, 92103, United States
Invivyd Investigative Site

Long Beach, California, 90806, United States
Invivyd Investigative Site

Orlando, Florida, 32819, United States
Invivyd Investigative Site

Hinesville, Georgia, 31313, United States
Invivyd Investigative Site

Melrose Park, Illinois, 60160, United States
Invivyd Investigative Site

Lenexa, Kansas, 66219, United States
Invivyd Investigative Site

Silver Spring, Maryland, 20904, United States
Invivyd Investigative Site

Burlington, Massachusetts, 01803, United States
Invivyd Investigative Site

Southfield, Michigan, 48034, United States
Invivyd Investigative Site

Maplewood, Minnesota, 55109, United States
Invivyd Investigative Site

Independence, Missouri, 64055, United States
Invivyd Investigative Site

Jersey City, New Jersey, 07306, United States
Invivyd Investigative Site

The Bronx, New York, 10455, United States
Invivyd Investigative Site

Philadelphia, Pennsylvania, 19107, United States
Invivyd Investigative Site

Myrtle Beach, South Carolina, 29572, United States
Invivyd Investigative Site

Goodlettsville, Tennessee, 37072, United States
Invivyd Investigative Site

Houston, Texas, 77065, United States
Invivyd Investigative Site

Houston-2, Texas, 77065, United States
Invivyd Investigative Site

Irving, Texas, 75061, United States
Invivyd Investigative Site

Sugar Land, Texas, 46254, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.